No price series to chart for IOBTQ.
IOBTQ is not in the screener universe; fundamentals are unavailable.
No price history for IOBTQ — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for IOBTQ, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.09T | 50.3 |
| JNJ | JOHNSON & JOHNSON | $616.50B | 23.2 |
| ONC | BeOne Medicines Ltd. | $465.49B | 1695.2 |
| ABBV | AbbVie Inc. | $454.79B | 109.1 |
| MRK | Merck & Co., Inc. | $320.56B | 17.8 |
| ABT | ABBOTT LABORATORIES | $183.95B | 28.4 |
| PFE | PFIZER INC | $141.97B | 18.3 |
| BMY | BRISTOL MYERS SQUIBB CO | $132.49B | 18.7 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $122.26B | 31.4 |
| REGN | REGENERON PHARMACEUTICALS, INC. | $69.37B | 17.8 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $41.26B | 29.3 |
| RPRX | Royalty Pharma plc | $33.31B | 33.2 |